Bargersville, IN, United States of America

Gregory Allan Sacha

USPTO Granted Patents = 5 

 

Average Co-Inventor Count = 3.1

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Greenwood, IN (US) (2013)
  • Bargersville, IN (US) (2013 - 2021)

Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Gregory Allan Sacha: Innovator in Antibody Formulations

Introduction

Gregory Allan Sacha is a notable inventor based in Bargersville, IN (US). He has made significant contributions to the field of biopharmaceuticals, particularly in the development of antibody formulations. With a total of 5 patents to his name, Sacha's work has the potential to impact therapeutic strategies significantly.

Latest Patents

Sacha's latest patents include innovative formulations for antibody and drug conjugates. One of his key patents discloses surfactant-free antibody and antibody-drug-conjugate (ADC) formulations for anti-AXL antibodies and ADCs. These formulations encompass aqueous, lyophilized, and reconstituted types, making them particularly suitable for anti-AXL ADCs based on hydrophobic drugs like auristatin or DM1 derivatives. Additionally, some formulations incorporate histidine and mannitol. Another significant patent relates to the preparation of lyophilized formulations of factor Xa (fXa) antidotes. This patent outlines methods for creating stable aqueous formulations that do not collapse during lyophilization, ensuring the efficacy of the antidote.

Career Highlights

Throughout his career, Gregory Allan Sacha has worked with prominent companies such as Baxter International Inc. and Baxter Healthcare SA. His experience in these organizations has allowed him to refine his expertise in biopharmaceutical development and contribute to groundbreaking innovations in the field.

Collaborations

Sacha has collaborated with talented professionals, including Wei Youh Kuu and Kelly Ann Roby. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to the development of effective therapeutic solutions.

Conclusion

Gregory Allan Sacha is a distinguished inventor whose work in antibody formulations is paving the way for advancements in biopharmaceuticals. His contributions, marked by multiple patents, reflect his commitment to innovation and improving therapeutic options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…